Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

NCT02435849

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Childrens Hospital Los Angeles SC CTL019 Los Angeles, California, United States
  • Stanford Universtiy Medical Center SC - CTL019B2205J - B2206 Stanford, California, United States
  • Children's Healthcare of Atlanta SC CTL019 Atlanta, Georgia, United States
  • University of Michigan . Ann Arbor, Michigan, United States
View all 23 locations
View Trial Details
Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

NCT01802814

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Australian & New Zealand Childhood Hematology & Oncology Group Clayton, Victoria, Australia
  • St. Anna Kinderkrebsforschung, CCRI Vienna, Austria
  • Hòpital Universitaire des Enfants Reine Fabiola Brussels, Belgium
  • University Hospital Motol Prague, Czechia
View all 17 locations
View Trial Details
Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details
Completed

Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01527149

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Occupational Status and Hematological Disease

NCT02057185

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti Genzano di Roma, Italy
  • Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy
  • U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy
View Trial Details
Completed

Study on Infectious Mononucleosis in Munich

NCT06002802

Conditions
DNA Virus Infections, Epstein-Barr Virus Infections, Hematologic Diseases, +11 more
Locations
  • MRI Chonic Fatigue Center for Young People (MCFC), Children's Hospital, Technical University of Munich & Munich Municipal Hospital Munich, Bavaria, Germany
View Trial Details

Related conditions